Clinical Validation Results of an Innovative Non-Invasive Device for Colorectal Cancer Preventive Screening through Fecal Exhalation Analysis
Screening is recommended to reduce both incidence and mortality of colorectal cancer. Currently, many countries employ fecal occult blood test (FOBT). In Emilia-Romagna (Italy), since 2005, FOBT immunochemical version (FIT) is performed every two years on people aged between 50 and 69 years. A colon...
Main Authors: | Giulia Zonta, Cesare Malagù, Sandro Gherardi, Alessio Giberti, Alessandro Pezzoli, Aldo De Togni, Caterina Palmonari |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/12/6/1471 |
Similar Items
-
Systematic Review of Fecal and Mucosa-Associated Microbiota Compositional Shifts in Colorectal Cancer
by: Zahra Karimi, et al.
Published: (2020-06-01) -
Practice of colorectal cancer screening in the United Arab Emirates and factors associated – a cross-sectional study
by: Latifa Nabeel Alsaad, et al.
Published: (2023-10-01) -
Fecal biomarkers: Non-invasive diagnosis of colorectal cancer
by: Qian Ding, et al.
Published: (2022-09-01) -
miRNA as a Biomarker for the Early Detection of Colorectal Cancer
by: David Coleman, et al.
Published: (2024-03-01) -
Towards Novel Non-Invasive Colorectal Cancer Screening Methods: A Comprehensive Review
by: Allegra Ferrari, et al.
Published: (2021-04-01)